1 Min Read
July 11 (Reuters) - Auscann Group Holdings Ltd
* Tasmanian Alkaloids has been granted a medicinal cannabis licence and a research and development licence from office of drug control. Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.